Physician profile
Jared S Preston
NPI 1063828762
$11,895.34
in general payments reported to CMS, 2019-2025
17 companies · $3,240 in 2025
The $3,240 reported for 2025 was more than what a typical Adult Reconstructive Orthopaedic Surgery provider received nationally (typical 2025 total: $1,425).
See the full distribution for Adult Reconstructive Orthopaedic Surgery
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $5,173 · 2021: $219 · 2022: $400 · 2023: $781 · 2024: $2,082 · 2025: $3,240.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,778 · Travel and Lodging: $2,325.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,778.10 |
| Travel and Lodging | $2,325.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $5,908.98 | 2020-2025 | Mako, Restoration, Gamma |
| Smith+Nephew, INC. | $4,500.00 | 2020 | |
| Bioventus LLC | $356.62 | 2022-2025 | Durolane, Xcell, L360 Thigh System |
| Zimmer Biomet Holdings, INC. | $301.60 | 2022-2025 | Rosa, Timberline Mpf Lateral Modular Plate Fixation System |
| Ferring Pharmaceuticals INC. | $194.16 | 2020-2025 | Euflexxa |
| Medical Device Business Services, INC. | $174.99 | 2020 | |
| Innovation Technologies INC | $132.68 | 2022-2024 | Irrisept |
| Depuy Synthes Sales INC. | $97.29 | 2020-2023 | Na |
| Sanofi-Aventis U.S. LLC | $65.97 | 2021-2022 | |
| Boston Scientific Corporation | $53.48 | 2021 | |
| Avanos Medical | $27.26 | 2021 | |
| Molnlycke Health Care US, LLC | $15.97 | 2023 | Avance |
| Kowa Pharmaceuticals America, INC. | $15.00 | 2022 | |
| Endo Pharmaceuticals INC. | $14.38 | 2021 | |
| Paragon 28, INC. | $14.25 | 2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vericel Corporation | $12.07 | 2022 | |
| Dynasplint Systems INC. | $10.64 | 2023 | Dynasplint |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jared Preston listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.